# Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects

> **NCT04592016** · NA · COMPLETED · sponsor: **Joanneum Research Forschungsgesellschaft mbH** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Voltaren - Diclofenac sodium gel 1% (GSK, USA)
- **DRUG:** Pennsaid 2 % Topical Solution (Horizon Therapeutics, USA)
- **DRUG:** Diclofenac sodium gel 1% (Perrigo, USA)
- **DEVICE:** Dermal open flow microperfusion - Pilot
- **DEVICE:** Dermal open flow microperfusion - Pivotal
- **PROCEDURE:** Blood sampling - Pilot
- **PROCEDURE:** Blood sampling - Pivotal

## Key facts

- **NCT ID:** NCT04592016
- **Lead sponsor:** Joanneum Research Forschungsgesellschaft mbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-08
- **Primary completion:** 2021-08-11
- **Final completion:** 2021-08-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592016, "Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04592016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*